Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study

PURPOSE: The aim of this study was to evaluate the dose-proportional pharmacokinetic characteristics of pregabalin following the administration of GLA5PR GLARS-NF1 tablets (150, 300, 450, and 600 mg) in the fed state. SUBJECTS AND METHODS: An open-label, randomized, single-dose, parallel study was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Kwang-Hee, Jeon, Ji-Young, Jang, Kyungho, Kim, Tae-Eun, Kim, Min-Gul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187918/
https://www.ncbi.nlm.nih.gov/pubmed/30349198
http://dx.doi.org/10.2147/DDDT.S167668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187918/
https://www.ncbi.nlm.nih.gov/pubmed/30349198
http://dx.doi.org/10.2147/DDDT.S167668

Ejemplares similares